利用雌激素的神经保护潜力减轻绝经后妇女的阿尔茨海默氏症病理:一篇评论
Makkapati Manasa1, Ganavi Bethanagere Ramesha1, K L Krishna1
1Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysore 570015, India.
Brain research
|February 23, 2026
概括
绝经后的女性更容易患上阿尔茨海默氏症 (AD). 雌激素通过减少粉样β和病理,减轻氧化应激,增强脑衍生神经营养因子 (BDNF) 信号传递来提供神经保护,可能有助于AD预防.
科学领域:
- 神经生物学 神经生物学 神经生物学
- 内分泌学 在内分泌学.
- 老年学是一门学科.
背景情况:
- 阿尔茨海默病 (AD) 不成比例地影响绝经后的女性.
- 雌激素通过多种途径参与神经保护,包括粉样β,,氧化应激和BDNF信号传递.
研究的目的:
- 审查雌激素在绝经后妇女中阿尔茨海默氏症病原体中的作用.
- 为了检查雌激素的神经保护机制和治疗相关性.
主要方法:
- 在PubMed,Scopus和Web of Science的系统文献搜索.
- 关键词:雌激素,阿尔茨海默病,神经保护,β-粉样蛋白,BDNF.
- 包括过去10年的同行评审研究,重点关注雌激素对AD机制的影响.
主要成果:
- 雌激素降低了粉样β负担和陶酸化.
- 雌激素减轻氧化应激,保持突触功能,并抑制神经炎症.
- 雌激素增强BDNF信号传递,支持神经元生存和认知性.
结论:
- 绝经后雌激素水平下降会增加AD的脆弱性.
- 了解雌激素的神经保护作用可以为向的AD疗法提供信息.
- 激素替代疗法 (HRT) 和SERM显示出潜力,但需要进一步的研究,以在AD预防和管理中最佳使用.
相关概念视频
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Menopause
5.0K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.0K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
718
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
718
Role of Neurotransmitters in Memory
2.7K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.7K


